CA50785-5A - 0x0000000000006BEC

Healthy Males & Females

Forward

* Stipend may pay up to reflected amount.
Start Date: 
September 8, 2026 - 2:00pm
End Date: 
September 16, 2026 - 8:30am

Study Details

Study Number: CA50785
Group Number: 5A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,250.00

Study Criteria

Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16

Study Schedule

Schedule Type: Short stays with returns
Study Length: 3 Night Stay & 2 Returns

Screening Dates:

Event Day Event Date
Friday 8/21/2026
Thursday 8/27/2026
Monday 8/31/2026

Doctor Exam Dates:

Event Day Event Date
Friday 8/21/2026
Thursday 8/27/2026
Monday 8/31/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 9/8/2026 2:00:00 PM Friday 9/11/2026 8:30:00 AM 1 Lincoln
Return Sunday 9/13/2026 7:30:00 AM Sunday 9/13/2026 8:30:00 AM 1 Lincoln
Return Wednesday 9/16/2026 7:30:00 AM Wednesday 9/16/2026 8:30:00 AM 1 Lincoln